Clinuvel Pharmaceuticals Limited (CLVLY)
OTCMKTS · Delayed Price · Currency is USD
7.30
+0.25 (3.51%)
Sep 5, 2025, 12:11 PM EDT

Clinuvel Pharmaceuticals Statistics

Total Valuation

CLVLY has a market cap or net worth of 371.02 million. The enterprise value is 224.30 million.

Market Cap371.02M
Enterprise Value 224.30M

Important Dates

The last earnings date was Friday, August 29, 2025.

Earnings Date Aug 29, 2025
Ex-Dividend Date Sep 9, 2024

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) -1.27%
Shares Change (QoQ) +0.44%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 41.43M

Valuation Ratios

The trailing PE ratio is 15.64 and the forward PE ratio is 14.97.

PE Ratio 15.64
Forward PE 14.97
PS Ratio 5.96
PB Ratio 2.35
P/TBV Ratio 2.35
P/FCF Ratio 13.87
P/OCF Ratio 13.77
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.29, with an EV/FCF ratio of 8.39.

EV / Earnings 9.46
EV / Sales 3.60
EV / EBITDA 7.29
EV / EBIT 7.47
EV / FCF 8.39

Financial Position

The company has a current ratio of 9.66, with a Debt / Equity ratio of 0.00.

Current Ratio 9.66
Quick Ratio 9.25
Debt / Equity 0.00
Debt / EBITDA 0.01
Debt / FCF 0.01
Interest Coverage 10.25

Financial Efficiency

Return on equity (ROE) is 16.30% and return on invested capital (ROIC) is 12.85%.

Return on Equity (ROE) 16.30%
Return on Assets (ROA) 11.37%
Return on Invested Capital (ROIC) 12.85%
Return on Capital Employed (ROCE) 18.71%
Revenue Per Employee 3.89M
Profits Per Employee 1.48M
Employee Count 16
Asset Turnover 0.38
Inventory Turnover 0.87

Taxes

In the past 12 months, CLVLY has paid 10.08 million in taxes.

Income Tax 10.08M
Effective Tax Rate 29.83%

Stock Price Statistics

The stock price has decreased by -31.01% in the last 52 weeks. The beta is 0.74, so CLVLY's price volatility has been lower than the market average.

Beta (5Y) 0.74
52-Week Price Change -31.01%
50-Day Moving Average 7.51
200-Day Moving Average 7.44
Relative Strength Index (RSI) 40.20
Average Volume (20 Days) 10,281

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, CLVLY had revenue of 62.29 million and earned 23.72 million in profits. Earnings per share was 0.47.

Revenue62.29M
Gross Profit 56.74M
Operating Income 30.00M
Pretax Income 33.80M
Net Income 23.72M
EBITDA 30.51M
EBIT 30.00M
Earnings Per Share (EPS) 0.47
Full Income Statement

Balance Sheet

The company has 146.93 million in cash and 346,508 in debt, giving a net cash position of 146.58 million.

Cash & Cash Equivalents 146.93M
Total Debt 346,508
Net Cash 146.58M
Net Cash Per Share n/a
Equity (Book Value) 157.88M
Book Value Per Share 3.15
Working Capital 154.57M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 26.94 million and capital expenditures -195,743, giving a free cash flow of 26.75 million.

Operating Cash Flow 26.94M
Capital Expenditures -195,743
Free Cash Flow 26.75M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is 91.08%, with operating and profit margins of 48.16% and 38.07%.

Gross Margin 91.08%
Operating Margin 48.16%
Pretax Margin 54.26%
Profit Margin 38.07%
EBITDA Margin 48.98%
EBIT Margin 48.16%
FCF Margin 42.94%

Dividends & Yields

This stock pays an annual dividend of 0.03, which amounts to a dividend yield of 0.43%.

Dividend Per Share 0.03
Dividend Yield 0.43%
Dividend Growth (YoY) 4.80%
Years of Dividend Growth 3
Payout Ratio 6.92%
Buyback Yield 1.27%
Shareholder Yield 1.69%
Earnings Yield 6.39%
FCF Yield 7.21%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

CLVLY has an Altman Z-Score of 14.53 and a Piotroski F-Score of 5.

Altman Z-Score 14.53
Piotroski F-Score 5